AMGEN Inc
NASDAQ: AMGN
$294.06
-$3.72 (-1.2%)
Real Time Data Delayed 15 Min.
AMGN Articles
U.S. equity markets opened higher this morning following a string of solid earnings reports yesterday and after markets closed last night. As we note below, earnings results were more mixed today,...
Published:
Last Updated:
thinkstock Today got off to a bit of a rocky start on earnings. McDonald’s Corp. (NYSE: MCD) beat estimates but not by much and growth appears to be stalled for the world’s largest fast food...
Published:
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Tuesday. Amgen Inc. (NASDAQ: AMGN) cut to Neutral at Credit Suisse. ARM Holdings...
Published:
Last Updated:
The week ahead will be the official flood gate opening for earnings season. We have a very large portion of the S&P 500 Index reporting fourth-quarter earnings, and we have many Dow Jones...
Published:
ThinkstockThe dread and fear that can come with a cancer diagnosis have their roots in its killer nature. It is the number two cause of death in Americans, second only to heart disease, according to...
Published:
Last Updated:
ThinkstockCancer ranks on the list of global killers as number two. Over the years, great strides have been made not only in cancer treatment but in survival rates for many different forms of the...
Published:
Last Updated:
ThinkstockBig biotech had a stellar 2012. In 2013, though, the large biotech companies may be dwarfed in performance by the smaller players in the $1 billion to $5 billion range. If you look at the...
Published:
Last Updated:
ThinkstockAmgen Inc. (NASDAQ: AMGN) is holding up better than some investors might have expected after the biotech giant warned about earnings. The lowering of earnings estimates was by a mere $0.10...
Published:
Jon OggThe largest biotech stocks have been great performers in 2012. The question is whether that can be sustained in 2013. If Wall St. analysts are correct, biotech and biohealth investors are...
Published:
Last Updated:
ThinkstockBiotech giant Amgen Inc. (NASDAQ: AMGN) made a series of moves after markets closed last night that appear to add up to an effort giving something to everybody. First out of the chute was a...
Published:
Last Updated:
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research calls this Wednesday. Align Technology Inc. (NASDAQ: ALGN) cut to Underperform as Bear of the...
Published:
Last Updated:
ThinkstockWe have tracked the key short interest changes in the following biotech and emerging pharma companies: Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), Amgen Inc. (NASDAQ: AMGN), Arena...
Published:
ThinkstockDividend stocks may have come under some pressure of late, but this is due to the demand for high dividends getting a bit crowded and ahead of the election. It also does not help that the...
Published:
We have tracked the key short interest changes in the following biotech and emerging pharma companies: Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), Amgen Inc. (NASDAQ: AMGN), Arena Pharmaceuticals...
Published:
Last Updated:
The three major U.S. stock indexes opened higher this morning following a better-than-expected PMI reading from China (more coverage here) that was mostly untempered by lower-than-expected PMI...
Published:
Last Updated:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.